✦ LIBER ✦

Prospective Randomized Phase III Trial of Etoposide/Cisplatin Versus High-Dose Epirubicin/Cisplatin in Small-Cell Lung Cancer

✍ Scribed by Angel Artal-Cortés; Jose Gomez-Codina; Jose Luis Gonzalez-Larriba; Isidoro Barneto; Alfredo Carrato; Dolores Isla; Carlos Camps; Carlos Garcia-Giron; Albert Font; Alfredo Meana; Maria Lomas; Catalina Vadell; Antonio Arrivi; Carmen Alonso; Inmaculada Maestu; Joaquin Cambell; Rafael Rosell

Book ID: 119935509
Publisher: CIG Media Group, LP.
Year: 2004
Tongue: English
Weight: 195 KB
Volume: 6
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2004.n.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized trial of high-dose epirubicin

Randomized trial of high-dose epirubicin-cisplatin (HDEP) versus etoposide-cisplatin (EP) in small cell lung cancer (SCLC). Study retrospective in older patients

✍ Camps, C; Artal, A; Gomez-Codina, J; Gonzalez-Larriba, J.L; Barneto, I; Carrato, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Randomized Phase III Trial of Cisplatin/

Randomized Phase III Trial of Cisplatin/Irinotecan Versus Cisplatin/Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer

✍ Primo N. Lara Jr; David R. Gandara; Ronald B. Natale 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 462 KB

Etoposide versus etoposide plus high-dos

Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer: Results of a prospective randomized fonicap trial

✍ Professor Riccardo Rosso; Franco Salvati; Andrea Ardizzoni; Corrado Gallo Curcio 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

1999 European Cancer Conference Summary

1999 European Cancer Conference Summary of Phase II Trials: Paclitaxel/Etoposide/Cisplatin versus Etoposide/Cisplatin for Small-Cell Lung Cancer

📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 451 KB

Economic evaluation in a randomized phas

Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer

✍ Sacristán, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Phase II feasibility study of high dose

Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer

✍ Rafael Rosell; Juan Carles; Albert Abad; Jose M. Jimeno; Isabel Moreno; Agustin 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 472 KB